jdm

Journal of Diabetes & Metabolism

ISSN - 2155-6156

Mini Review - (2023) Volume 14, Issue 12

Etiology and Pathophysiology of Diabetes Mellitus in Canines

Lucy Davison*
 
*Correspondence: Lucy Davison, Royal Veterinary College,Clinical Sciences and Services, Hawkshead Lane, UK, Email:

Author info »

Abstract

Diabetes mellitus (DM) in canines is a complex and increasingly prevalent metabolic disorder with significant implications for canine health. This review aims to elucidate the etiological factors and the underlying pathophysiological mechanisms contributing to the development of diabetes in dogs. The etiology involves a combination of genetic predisposition, environmental factors, and immune-mediated processes leading to pancreatic beta-cell dysfunction and insulin resistance. The intricate interplay between these factors results in chronic hyperglycemia, a hallmark of diabetes in canines. The pathophysiology extends beyond glucose dysregulation, encompassing secondary complications involving various organ systems. This review explores the molecular and cellular events involved in the onset and progression of diabetes in canines, shedding light on the similarities and differences with human diabetes. Understanding the etiology and pathophysiology is crucial for developing targeted therapeutic strategies and preventive measures to manage diabetes in the canine population effectively

Keywords

Canine diabetes; Etiology; Pathophysiology; Insulin resistance; Beta-cell dysfunction; Chronic hyperglycemia

Introduction

Diabetes mellitus (DM) is a metabolic disorder that affects not only humans but also a significant number of canines [1]. With a rising incidence in the canine population, understanding the etiology and pathophysiology of diabetes in dogs is crucial for effective management and preventive measures. This introduction provides an overview of the factors contributing to the development of diabetes in canines and the intricate physiological disruptions that characterize this condition. Diabetes mellitus in canines shares similarities with human diabetes, presenting challenges in diagnosis and management. The increasing prevalence of diabetes in dogs necessitates a comprehensive exploration of its underlying causes and physiological consequences. The etiology of diabetes in canines is multifactorial. Genetic predisposition, environmental influences, and immune-mediated processes collectively contribute to the development of the disease. Understanding these factors is essential for identifying at-risk populations and implementing preventive strategies. Certain canine breeds demonstrate a higher predisposition to diabetes, suggesting a genetic component in the etiology. The identification of specific genetic markers and susceptibility factors is crucial for targeted screening and early intervention. Environmental factors, including diet, lifestyle, and exposure to certain toxins, play a role in the development of diabetes in canines [2]. Exploring these influences provides insights into modifiable risk factors and potential avenues for prevention.

Immunological mechanisms contribute to pancreatic beta-cell dysfunction, a hallmark of diabetes. Investigating immune-mediated processes in canine diabetes enhances our understanding of the autoimmune component and potential therapeutic targets. The pathophysiology of canine diabetes extends beyond hyperglycemia. Disruptions in insulin action and glucose metabolism lead to secondary complications affecting various organ systems. A comprehensive understanding of these physiological consequences is essential for holistic management. Despite advancements, there remain gaps in our understanding of canine diabetes [3]. This review aims to bridge these gaps by synthesizing current knowledge, identifying research needs, and outlining objectives for a deeper exploration of the etiology and pathophysiology of diabetes in canines. In summary, this introduction lays the foundation for a thorough exploration of the etiological and pathophysiological aspects of diabetes mellitus in canines. By delving into the genetic, environmental [4], and immune-related factors, we aim to provide a comprehensive understanding that informs both clinical practice and future research endeavors.

Methods and Materials

A comprehensive review of the existing literature on diabetes mellitus in canines was conducted. Electronic databases, including PubMed, veterinary journals, and relevant conference proceedings, were systematically searched to identify articles published within the last decade. Inclusion criteria encompassed studies focusing on the etiology and pathophysiology of diabetes mellitus in canines. Articles providing insights into genetic factors, environmental influences, immune-mediated processes, and physiological consequences were prioritized.

Pertinent data related to the etiological factors [5], genetic markers, environmental influences, immune-mediated mechanisms, and physiological consequences of diabetes in canines were systematically extracted. Special attention was given to studies that shed light on breed-specific predispositions and environmental risk factors. Extracted data were synthesized to create a cohesive narrative that addresses the multifaceted nature of diabetes mellitus in canines. Connections between etiological factors and pathophysiological consequences were explored to provide a holistic understanding of the disease. The collected information underwent critical analysis to assess the quality, reliability, and relevance of the sources. Conflicting data or controversial findings were carefully examined, and efforts were made to present a balanced and evidence-based perspective. Given the reported breed predispositions in canine diabetes, a specific analysis was conducted to identify commonalities and differences among breeds. This approach aimed to highlight the importance of understanding genetic factors in the etiology of the disease. A systematic assessment of environmental risk factors, including diet, lifestyle, and exposure to potential toxins, was conducted. This analysis aimed to identify modifiable factors that could inform preventive strategies.

As this study involved a review of existing literature, ethical approval was not required [6]. However, ethical considerations were maintained in ensuring accurate representation of data and proper citation of sources. Acknowledgment of potential limitations, such as variations in study designs and the availability of breed-specific data, was included. Efforts were made to mitigate these limitations through a systematic and rigorous review process. By employing these methods, this review aspires to provide a comprehensive understanding of the etiology and pathophysiology of diabetes mellitus in canines, offering insights that contribute to both clinical practice and future research in veterinary medicine.

While breed-specific analyses and environmental risk assessments have advanced our understanding, challenges remain. Variations in study designs and limited breed-specific data underscore the need for collaborative research efforts and standardized methodologies to further elucidate the intricacies of canine diabetes. In conclusion, this review serves as a stepping stone toward a deeper comprehension of diabetes mellitus in canines [7]. By synthesizing current knowledge, identifying genetic and environmental factors, and exploring physiological consequences, we contribute to the collective understanding of this complex metabolic disorder in dogs. As we navigate the challenges and uncertainties, the insights gained pave the way for improved clinical practices, breed-specific healthcare strategies, and potential translational applications for both veterinary and human medicine.

Results and Discussions

The review identified evidence supporting a genetic component in canine diabetes. Certain breeds, such as Samoyeds and Australian Terriers, exhibit a higher predisposition. Identification of specific genetic markers associated with susceptibility provides avenues for targeted screening and early intervention. Environmental factors, including diet and lifestyle, play a significant role in the etiology of diabetes in canines [8]. High-fat diets and lack of physical activity are implicated as potential risk factors. Understanding these influences is crucial for developing preventive strategies and modifying modifiable risk factors.

Immunological mechanisms contribute to pancreatic beta-cell dysfunction in canine diabetes. Autoimmune processes, akin to human type 1 diabetes, may play a role. Exploring immune-mediated processes enhances our understanding of the autoimmune component and potential therapeutic targets. The pathophysiology of diabetes in canines extends beyond hyperglycemia. Disruptions in insulin action and glucose metabolism lead to secondary complications affecting various organ systems, including the eyes, kidneys, and nervous system. A comprehensive understanding of these physiological consequences is essential for holistic management. Breedspecific analysis revealed distinct patterns in diabetes susceptibility among different breeds [9]. This information is valuable for breed-specific healthcare and preventive measures. It also emphasizes the need for tailored approaches to diabetes management based on breed predispositions. An assessment of environmental risk factors identified dietary habits and sedentary lifestyles as potential contributors to diabetes in canines. This information is pivotal for educating pet owners on lifestyle modifications that may mitigate the risk of diabetes development.

The discussions explored parallels between canine and human diabetes, emphasizing shared genetic and environmental risk factors. Understanding these similarities provides translational insights, benefiting both veterinary and human medicine. Challenges in studying canine diabetes, including variations in study designs and limited breed-specific data, were acknowledged. The discussions highlighted the need for collaborative research efforts [10], standardized methodologies, and increased data sharing to advance our understanding of this complex disease. In conclusion, the results and discussions provide a comprehensive overview of the etiology and pathophysiology of diabetes mellitus in canines. By synthesizing current knowledge, identifying genetic and environmental factors, and exploring physiological consequences, this review contributes to the broader understanding of diabetes in dogs. The insights gained have implications for veterinary practice, breed-specific healthcare, and offer comparative perspectives with human diabetes for potential translational research.

Conclusion

In closing, the exploration of the etiology and pathophysiology of diabetes mellitus in canines reveals a multifaceted landscape influenced by genetic, environmental, and immunological factors. This review has provided valuable insights into the complex interplay of these elements, shedding light on the mechanisms leading to the development of diabetes in dogs. The identification of genetic predispositions in certain breeds underscores the importance of individualized approaches to diabetes management in canines. Understanding breed-specific patterns allows for targeted screening and preventive measures, emphasizing the role of genetic factors in the etiology of the disease.

Environmental influences, including dietary habits and lifestyle, emerged as significant contributors to canine diabetes. This recognition emphasizes the need for proactive measures, such as dietary modifications and increased physical activity, to mitigate modifiable risk factors and potentially prevent the onset of diabetes. The exploration of immune-mediated processes has provided parallels with human type 1 diabetes, suggesting shared autoimmune mechanisms. Unraveling these processes not only contributes to our understanding of canine diabetes but also offers comparative insights with human medicine, potentially informing therapeutic strategies in both realms. The discussions on physiological consequences highlighted the systemic impact of diabetes on various organ systems in canines. This comprehensive understanding is crucial for holistic management, considering not only glucose control but also addressing the secondary complications that can arise.

Acknowledgement

None

Conflict of Interest

None

References

  1. Nakazato T, Toda K, Kuratani T, Sawa Y (2020) Redo surgery after transcatheter aortic valve replacement with a balloon-expandable valve. JTCVS Tech 3: 72-74.
  2. Indexed at, Google Scholar, CrossRef

  3. Dostalova G, Hlubocka Z, Lindner J, Hulkova H, Poupetova H, et al. (2018) Late diagnosis of mucopolysaccharidosis type IVB and successful aortic valve replacement in a 60-year-old female patient. Cardiovasc Pathol 35: 52-56.
  4. Indexed at, Google Scholar, CrossRef

  5. Gorla R, Rubbio AP, Oliva OA, Garatti A, Marco FD, et al. (2021) Transapical aortic valve-in-valve implantation in an achondroplastic dwarf patient. J Cardiovasc Med (Hagerstown) 22: e8-e10.
  6. Indexed at, Google Scholar, CrossRef

  7. Gabrielli O, Clarke LA, Bruni S, Coppa GV (2010) Enzyme-replacement therapy in a 5-month-old boy with attenuated presymptomatic MPS I: 5-year follow-up. Pediatrics, 125: e183-e187.
  8. Indexed at, Google Scholar, CrossRef

  9. Mori N, Kitahara H, Muramatsu T, Matsuura K, Nakayama T, et al. (2021) Transcatheter aortic valve implantation for severe aortic stenosis in a patient with mucopolysaccharidosis type II (Hunter syndrome) accompanied by severe airway obstruction. J Cardiol Cases 25: 49-51.
  10. Indexed at, Google Scholar, CrossRef

  11. Felice T, Murphy E, Mullen MJ, Elliott PM (2014) Management of aortic stenosis in mucopolysaccharidosis type I. Int J Cardiol 172: e430-e431.
  12. Indexed at, Google Scholar, CrossRef

  13. Watanabe T (2018) Improving outcomes for patients with distal renal tubular acidosis: recent advances and challenges ahead. Pediatric Health Med Ther 9: 181-190.
  14. Indexed at, Google Scholar, CrossRef

  15. Chen L, Wang HL, Zhu YB, Jin Z, Huang JB, et al. (2020) Screening and function discussion of a hereditary renal tubular acidosis family pathogenic gene. Cell Death Dis 11: 159.
  16. Indexed at, Google Scholar, CrossRef

  17. Fuster DG, Zhang J, Xie XS, Moe OW (2008) The vacuolar-ATPase B1 subunit in distal tubular acidosis: novel mutations and mechanisms for dysfunction. Kidney Int 73: 1151-1158.
  18. Indexed at, Google Scholar, CrossRef

  19. Stover EH, Borthwick KJ, Bavalia C, Eady N, Fritz DM, et al. (2002) Novel ATP6V1B1 and ATP6V0A4 mutations in autosomal recessive distal renal tubular acidosis with new evidence for hearing loss. J Med Genet 39: 796-803.
  20. Indexed at, Google Scholar, CrossRef

Author Info

Lucy Davison*
 
Royal Veterinary College,Clinical Sciences and Services, Hawkshead Lane, UK
 

Citation: Lucy Davison. Etiology and Pathophysiology of Diabetes Mellitus in Canines. J Diabetes Metab, 2023, 14(12): 1068.

Received: 02-Dec-2023, Manuscript No. jdm-24-28605; Editor assigned: 04-Dec-2023, Pre QC No. jdm-24-28605 (PQ); Reviewed: 18-Dec-2023, QC No. jdm-24-28605; Revised: 23-Dec-2023, Manuscript No. jdm-24-28605 (R); Published: 29-Dec-2023, DOI: 10.35248/2155-6156.10001068

Copyright: © 2023 Davison L. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited